Zentiva

News

Ex-Sanofi generics company Zentiva is poised for a sale by current owner Advent International to US investment group GTCR, says a media report.

News

Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International.

News

Sanofi's CEO says adding to the group's pipeline through M&A and licensing will be "critical" as it prepares for generic competition to Dupixent.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.